منابع مشابه
Irrational exuberance in clinical proteomics.
Is the siren call of ‘‘omics’’-based tests luring researchers, physicians, patients, and entrepreneurs onto the rocks of unproven and unapprovable diagnostics technology, or will the winds of technological change enable them to reach the beachhead safely? In the marketplace, patients and caregivers welcome minimally invasive tests enabling improved decision making and better outcomes. Thanks to...
متن کاملFinancial Fragility with Rational and Irrational Exuberance
This article formalizes investor rationality and irrationality, exuberance and apprehension, to consider the implications of belief formation for the fragility of an economy’s financial structure. The model presented generates a financial structure with portfolio linkages that make it susceptible to contagious financial crises, despite the absence of coordination failures. Investors forecast th...
متن کاملIrrational exuberance for resolved species trees.
Phylogenomics has largely succeeded in its aim of accurately inferring species trees, even when there are high levels of discordance among individual gene trees. These resolved species trees can be used to ask many questions about trait evolution, including the direction of change and number of times traits have evolved. However, the mapping of traits onto trees generally uses only a single rep...
متن کاملAvoiding Irrational NeuroLaw Exuberance: A Plea for Neuromodesty
"In a 2002 editorial published in The Economist, the following warning was given: "Genetics may yet threaten privacy, kill autonomy, make society homogeneous and gut the concept of human nature. But neuroscience could do all of these things first." The genome was fully sequenced in 2001, and there has not been one resulting major advance in therapeutic medicine since. Thus, even in its most nat...
متن کاملThe growth of psychopharmacology in the 1990s: evidence-based practice or irrational exuberance.
The rapid growth in sales of psychotropic medications during the late 1980s and 1990s, eventually reaching $20 billion/year, reflected the increased use of seritonin reuptake inhibitors for depression and atypical antipsychotics for schizophrenia. Recently, however, some of the therapeutic claims for these medications have been challenged, and under-appreciated risks have turned out to be signi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of General Internal Medicine
سال: 2017
ISSN: 0884-8734,1525-1497
DOI: 10.1007/s11606-017-4142-7